- Home
- ABOS vs TOYO Comparison
ABOS vs TOYO Comparison
Compare ABOS & TOYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- TOYO
- Stock Information
- Founded
- ABOS 1996
- TOYO 2022
- Country
- ABOS United States
- TOYO Japan
- Employees
- ABOS N/A
- TOYO N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- TOYO
- Sector
- ABOS Health Care
- TOYO
- Exchange
- ABOS Nasdaq
- TOYO NYSE
- Market Cap
- ABOS 138.8M
- TOYO 115.2M
- IPO Year
- ABOS 2021
- TOYO N/A
- Fundamental
- Price
- ABOS $1.92
- TOYO $3.62
- Analyst Decision
- ABOS Strong Buy
- TOYO
- Analyst Count
- ABOS 4
- TOYO 0
- Target Price
- ABOS $9.00
- TOYO N/A
- AVG Volume (30 Days)
- ABOS 268.9K
- TOYO 2.6M
- Earning Date
- ABOS 11-12-2024
- TOYO 08-21-2024
- Dividend Yield
- ABOS N/A
- TOYO N/A
- EPS Growth
- ABOS N/A
- TOYO N/A
- EPS
- ABOS N/A
- TOYO 0.76
- Revenue
- ABOS N/A
- TOYO $200,455,385.00
- Revenue This Year
- ABOS N/A
- TOYO N/A
- Revenue Next Year
- ABOS N/A
- TOYO N/A
- P/E Ratio
- ABOS N/A
- TOYO $4.58
- Revenue Growth
- ABOS N/A
- TOYO N/A
- 52 Week Low
- ABOS $1.91
- TOYO $1.36
- 52 Week High
- ABOS $5.09
- TOYO $15.61
- Technical
- Relative Strength Index (RSI)
- ABOS 32.44
- TOYO N/A
- Support Level
- ABOS $1.91
- TOYO N/A
- Resistance Level
- ABOS $2.03
- TOYO N/A
- Average True Range (ATR)
- ABOS 0.12
- TOYO 0.00
- MACD
- ABOS -0.02
- TOYO 0.00
- Stochastic Oscillator
- ABOS 6.00
- TOYO 0.00
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About TOYO TOYO CO LTD
Toyo Co Ltd along with its subsidiaries is engaged in research and development, production, and sales of solar cells.